Directing the immune system with chemical compounds

ACS Chemical Biology

Volumn 9, Issue 5, 2014, Pages 1075-1085

  Mancini, Rock J ^a   Stutts, Lalisa ^a   Ryu, Keun Ah ^a   Tom, Janine K ^a   Esser Kahn, Aaron P ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PATTERN RECOGNITION RECEPTOR; PHOSPHORYL LIPID A; PROTEIN MD 2; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 1; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 5; TOLL LIKE RECEPTOR 6; TOLL LIKE RECEPTOR 7; TOLL LIKE RECEPTOR 8; TOLL LIKE RECEPTOR 9; TOLL LIKE RECEPTOR AGONIST; IMMUNOLOGICAL ADJUVANT;

ADAPTIVE IMMUNITY; ANTIBODY TITER; ANTIGEN PRESENTING CELL; ARTICLE; BINDING SITE; BONE MARROW CELL; CELL ACTIVATION; CELL MATURATION; CELLULAR IMMUNITY; CPG ISLAND; CRYSTAL STRUCTURE; CYTOKINE RELEASE; DENDRITIC CELL; DIMERIZATION; ENDOSOME; IMMUNE RESPONSE; IMMUNE SYSTEM; IMMUNOSTIMULATION; INNATE IMMUNITY; LANGERHANS CELL; MOLECULAR INTERACTION; PLASMACYTOID DENDRITIC CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN MOTIF; RECEPTOR BINDING; SIGNAL TRANSDUCTION; STATIC ELECTRICITY; STEREOCHEMISTRY; AGONISTS; ANIMAL; CHEMICAL STRUCTURE; CHEMISTRY; DRUG EFFECTS; HUMAN; IMMUNOLOGY;

ADAPTIVE IMMUNITY; ADJUVANTS, IMMUNOLOGIC; ANIMALS; HUMANS; IMMUNE SYSTEM; IMMUNITY, INNATE; MODELS, MOLECULAR; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTORS;

EID: 84900850520     PISSN: 15548929     EISSN: 15548937     Source Type: Journal    
DOI: 10.1021/cb500079s     Document Type: Article

References (100)

1. Kang, J. Y. and Lee, J.-O. (2011) Structural biology of the Toll-like receptor family Annu. Rev. Biochem. 80, 917-941
2. Marshak-Rothstein, A. (2006) Toll-like receptors in systemic autoimmune disease Nat. Rev. Immunol. 6, 823-835
3. Ahmed, R. and Pulendran, B. (2011) Learning vaccinology from viral infections J. Exp. Med. 208, 2347-2349
4. Kumar, H., Kawai, T., and Akira, S. (2011) Pathogen recognition by the innate immune system Int. Rev. Immunol. 30, 16-34
5. Mogensen, T. H. (2009) Pathogen recognition and inflammatory signaling in innate immune defenses Clin. Microbiol. Rev. 22, 240-273
6. Tom, J. K., Mancini, R. J., and Esser-Kahn, A. P. (2013) Covalent modification of cell surfaces with TLR agonists improves and directs immune stimulation Chem. Commun. 49, 9618-9620
7. Kasturi, S. P., Skountzou, I., Albrecht, R. A., Koutsonanos, D., Hua, T., Nakaya, H. I., Ravindran, R., Stewart, S., Alam, M., Kwissa, M., Villinger, F., Murthy, N., Steel, J., Jacob, J., Hogan, R. J., Garcia-Sastre, A., Compans, R., and Pulendran, B. (2011) Programming the magnitude and persistence of antibody responses with innate immunity Nature 470, 543-547
8. Zhu, Q., Egelston, C., Vivekanandhan, A., Uematsu, S., Akira, S., Klinman, D. M., Belyakov, I. M., and Berzofsky, J. A. (2008) Toll-like receptor ligands synergize through distinct dendritic cell pathways to induce T cell responses: Implications for vaccines Proc. Natl. Acad. Sci. U.S.A. 105, 16260-16265
9. Kiessling, L. L. and Grim, J. C. (2013) Glycopolymer probes of signal transduction Chem. Soc. Rev. 42, 4476-4491
10. Pulendran, B. and Ahmed, R. (2011) Immunological mechanisms of vaccination Nat. Immunol. 131, 509-517
11. Nabel, G. J. (2013) Designing tomorrows vaccines N. Engl. J. Med. 368, 551-560
12. Applequist, S. E., Wallin, R. P. A., and Ljunggren, H.-G. (2002) Variable expression of Toll-like receptor in murine innate and adaptive immune cell lines Int. Immunol. 14, 1065-1074
13. Berti, F. and Adamo, R. (2013) Recent mechanistic insights on glycoconjugate vaccines and future perspectives ACS Chem. Biol. 8, 1653-1663
14. Huang, Q., Liu, D., Majewski, P., Schulte, L. C., Korn, J. M., Young, R. A., Lander, E. S., and Hacohen, N. (2001) The plasticity of dendritic cell responses to pathogens and their components Science 294, 870-875
15. Steinman, R. M. (2012) Decisions about dendritic cells: past, present, and future Annu. Rev. Immunol. 30, 1-22
16. Rowley, D. A. and Fitch, F. W. (2012) The road to the discovery of dendritic cells, a tribute to Ralph Steinman Cell. Immunol. 273, 95-98
17. Barton, G. M. and Kagan, J. C. (2009) A cell biological view of Toll-like receptor function: regulation through compartmentalization Nat. Rev. Immunol. 9, 535-542
18. Takeuchi, O. and Akira, S. (2010) Pattern recognition receptors and inflammation Cell 140, 805-820
19. West, M. A., Wallin, R. P. A., Matthews, S. P., Svensson, H. G., Zaru, R., Ljunggren, H.-G., Prescott, A. R., and Watts, C. (2004) Enhanced dendritic cell antigen capture via Toll-like receptor-induced actin remodeling Science 305, 1153-1157
20. Ewald, S. E., Lee, B. L., Lau, L., Wickliffe, K. E., Shi, G.-P., Chapman, H. A., and Barton, G. M. (2008) The ectodomain of Toll-like receptor 9 is cleaved to generate a functional receptor Nature 456, 658-662
21. Jin, M. S., Kim, S. E., Heo, J. Y., Lee, M. E., Kim, H. M., Paik, S.-G., Lee, H., and Lee, J.-O. (2007) Crystal structure of the TLR1-TLR2 heterodimer induced by binding of a tri-acylated lipopeptide Cell 130, 1071-1082
22. Manavalan, B., Basith, S., and Choi, S. (2011) Similar structures but different roles-An updated perspective on TLR structures Front. Physiol. 10.3389/fphys.2011.00041
23. Berg, M., Offermanns, S., Seifert, R., and Schultz, G. (1994) Synthetic lipopeptide Pam(3)cysser(lys)(4) is an effective activator of human platelets Am. J. Physiol. 266, C1684-C1691
24. Wiesmuller, K., Bessler, W., and Jung, G. (1983) Synthesis of the mitogenic S-[2,3-bis(palmitoyloxy)propyl]-N-palmitoylpentapeptide from Escherichia coli lipoprotein Hoppe Seylers Z. Physiol. Chem. 364, 593-606
25. Zhang, Y., Luo, F., Cai, Y., Liu, N., Wang, L., Xu, D., and Chu, Y. (2011) TLR1/TLR2 agonist induces tumor regression by reciprocal modulation of effector and regulatory T cells J. Immunol 186, 1963-1969
26. Van Duin, D., Medzhitov, R., and Shaw, A. C. (2006) Triggering TLR signaling in vaccination Trends Immunol. 27, 49-55
27. Seong, S.-Y. and Matzinger, P. (2004) Hydrophobicity: an ancient damage-associated molecular pattern that initiates innate immune responses Nat. Rev. Immunol 4, 469-478
28. Zaehringer, U., Lindner, B., Inamura, S., Heine, H., and Alexander, C. (2008) TLR2-promiscuous or specific? A critical re-evaluation of a receptor expressing apparent broad specificity Immunobiology 213, 205-224
29. Ray, A., Cot, M., Puzo, G., Gilleron, M., and Nigou, J. (2013) Bacterial cell wall macroamphiphiles: Pathogen-/microbe-associated molecular patterns detected by mammalian innate immune system Biochimie 95, 33-42
30. Salunke, D. B., Shukla, N. M., Yoo, E., Crall, B. M., Balakrishna, R., Malladi, S. S., and David, S. A. (2012) Structure-activity relationships in human Toll-like receptor 2-specific monoacyl lipopeptides J. Med. Chem. 55, 3353-3363
31. Agnihotri, G., Crall, B. M., Lewis, T. C., Day, T. P., Balakrishna, R., Warshakoon, H. J., Malladi, S. S., and David, S. A. (2011) Structure-activity relationships in Toll-like receptor 2-agonists leading to simplified monoacyl lipopeptides J. Med. Chem. 54, 8148-8160
32. Sato, M., Sano, H., Iwaki, D., Kudo, K., Konishi, M., Takahashi, H., Takahashi, T., Imaizumi, H., Asai, Y., and Kuroki, Y. (2003) Direct binding of Toll-like receptor 2 to zymosan, and zymosan-induced NF-kappa B activation and TNF-alpha secretion are down-regulated by lung collectin surfactant protein A J. Immunol. 171, 417-425
33. Tsai, C.-C., Lin, C.-R., Tsai, H.-Y., Chen, C.-J., Li, W.-T., Yu, H.-M., Ke, Y.-Y., Hsieh, W.-Y., Chang, C.-Y., Wu, C.-Y., Chen, S.-T., and Wong, C.-H. (2013) The immunologically active oligosaccharides isolated from wheatgrass modulate monocytes via Toll-like receptor-2 signaling J. Biol. Chem. 288, 17689-17697
34. Sahoo, B. R., Basu, M., Swain, B., Dikhit, M. R., Jayasankar, P., and Samanta, M. (2013) Elucidation of novel structural scaffold in Rohu TLR2 and its binding site analysis with peptidoglycan, lipoteichoic acid and zymosan ligands, and downstream MyD88 adaptor protein BioMed Res. Int. 10.1155/2013/185282
35. Buwitt-Beckmann, U., Heine, H., Wiesmuller, K.-H., Jung, G., Brock, R., Akira, S., and Ulmer, A. (2005) Toll-like receptor 6-independent signaling by diacylated lipopeptides Eur. J. Immunol. 35, 282-289
36. Guan, Y., Omueti-Ayoade, K., Mutha, S. K., Hergenrother, P. J., and Tapping, R. I. (2010) Identification of novel synthetic toll-like receptor 2 agonists by high throughput screening J. Biol. Chem. 285, 23755-23762
37. Kang, J. Y., Nan, X., Jin, M. S., Youn, S.-J., Ryu, Y. H., Mah, S., Han, S. H., Lee, H., Paik, S.-G., and Lee, J.-O. (2009) Recognition of lipopeptide patterns by Toll-like receptor 2-Toll-like receptor 6 heterodimer Immunity 31, 873-884
38. Ginsburg, I. (2002) Role of lipoteichoic acid in infection and inflammation Lancet Infect. Dis. 2, 171-179
39. Stadelmaier, A., Morath, S., Hartung, T., and Schmidt, R. R. (2003) Synthesis of the first fully active lipoteichoic acid Angew. Chem., Int. Ed. 42, 916-920
40. Metzger, J. W., Beck-Sickinger, A. G., Loleit, M., Eckert, M., Bessler, W. G., and Jung, G. (1995) Synthetic S-(2,3-dihydroxypropyl)-cysteinyl peptides derived from the N-terminus of the cytochrome subunit of the photoreaction centre of Rhodopseudomonas viridis enhance murine splenocyte proliferation J. Pept. Sci. 1, 184-190
41. Ohto, U., Fukase, K., Miyake, K., and Shimizu, T. (2012) Structural basis of species-specific endotoxin sensing by innate immune receptor TLR4/MD-2 Proc. Natl. Acad. Sci. U.S.A. 109, 7421-7426
42. Park, B. S., Song, D. H., Kim, H. M., Choi, B.-S., Lee, H., and Lee, J.-O. (2009) The structural basis of lipopolysaccharide recognition by the TLR4-MD-2 complex Nature 458, 1191-1195
43. Stover, A. G. (2003) Structure-activity relationship of synthetic Toll-like receptor 4 agonists J. Biol. Chem. 279, 4440-4449
44. Coler, R. N., Baldwin, S. L., Shaverdian, N., Bertholet, S., Reed, S. J., Raman, V. S., Lu, X., DeVos, J., Hancock, K., Katz, J. M., Vedvick, T. S., Duthie, M. S., Clegg, C. H., Van Hoeven, N., and Reed, S. G. (2010) A synthetic adjuvant to enhance and expand immune responses to influenza vaccines PLoS One 5, e13677
45. Coler, R. N., Bertholet, S., Moutaftsi, M., Guderian, J. A., Windish, H. P., Baldwin, S. L., Laughlin, E. M., Duthie, M. S., Fox, C. B., Carter, D., Friede, M., Vedvick, T. S., Reed, S. G., and Halford, W. (2011) Development and characterization of synthetic glucopyranosyl lipid adjuvant system as a vaccine adjuvant PLoS One 6 e16333
46. Needham, B. D., Carroll, S. M., Giles, D. K., Georgiou, G., Whiteley, M., and Trent, M. S. (2013) Modulating the innate immune response by combinatorial engineering of endotoxin Proc. Natl. Acad. Sci. U.S.A. 110, 1464-1469
47. Mata-Haro, V., Cekic, C., Martin, M., Chilton, P. M., Casella, C. R., and Mitchell, T. C. (2007) The vaccine adjuvant monophosphoryl Lipid A as a TRIF-biased agonist of TLR4 Science 316, 1628-1632
48. Gangloff, M. (2012) Different dimerisation mode for TLR4 upon endosomal acidification? Trends Biochem. Sci. 37, 92-98
49. Bowen, W. S., Minns, L. A., Johnson, D. A., Mitchell, T. C., Hutton, M. M., and Evans, J. T. (2012) Selective TRIF-dependent signaling by a synthetic Toll-like receptor 4 agonist Sci. Signaling 5, ra13-ra13
50. Trompette, A., Divanovic, S., Visintin, A., Blanchard, C., Hegde, R. S., Madan, R., Thorne, P. S., Wills-Karp, M., Gioannini, T. L., Weiss, J. P., and Karp, C. L. (2008) Allergenicity resulting from functional mimicry of a Toll-like receptor complex protein Nature 457, 585-588
51. Bryant, C. E., Spring, D. R., Gangloff, M., and Gay, N. J. (2009) The molecular basis of the host response to lipopolysaccharide Nat. Rev. Microbiol. 8, 8-14
52. Shanmugam, A., Rajoria, S., George, A. L., Mittelman, A., Suriano, R., and Tiwari, R. K. (2012) Synthetic Toll like receptor-4 (TLR-4) agonist peptides as a novel class of adjuvants PLoS One 7, e30839
53. Ohashi, K., Burkart, V., Flohé, S., and Kolb, H. (2000) Cutting edge: Heat Shock Protein 60 is a putative endogenous ligand of the Toll-like receptor-4 complex J. Immunol. 164, 558
54. Asea, A. (2002) Novel signal transduction pathway utilized by extracellular HSP70. Role of Toll-like receptor (TLR) 2 and TLR4 J. Biol. Chem. 277, 15028-15034
55. Smiley, S. T., King, J. A., and Hancock, W. W. (2001) Fibrinogen stimulates macrophage chemokine secretion through Toll-like receptor 4 J. Immunol. 167, 2887
56. Okamura, Y., Watari, M., Jerud, E. S., Young, D. W., Ishizaka, S. T., Rose, J., Chow, J. C., and Stauss, J. F., III (2001) The extra domain A of fibronectin activates Toll-like receptor 4 J. Biol. Chem. 276, 10229-10233
57. Semeraro, F., Ammollo, C. T., Morrissey, J. H., Dale, G. L., Friese, P., Esmon, N. L., and Esmon, C. T. (2011) Extracellular histones promote thrombin generation through platelet-dependent mechanisms: involvement of platelet TLR2 and TLR4 Blood 118, 1952-1961
58. Chan, M., Hayashi, T., Mathewson, R. D., Nour, A., Hayashi, Y., Yao, S., Tawatao, R. I., Crain, B., Tsigelny, I. F., Kouznetsova, V. L., Messer, K., Pu, M., Corr, M., Carson, D. A., and Cottam, H. B. (2013) Identification of substituted pyrimido[5,4-b ]indoles as selective Toll-like receptor 4 ligands J. Med. Chem. 56, 4206-4223
59. Latz, E., Verma, A., Visintin, A., Gong, M., Sirois, C., Klein, D., Monks, B., McKnight, C. J., Lamphier, M., Duprex, P., Espevik, T., and Golenbock, D. (2007) Ligand-induced conformational changes allosterically activate Toll-like receptor 9 Nature 8, 772-779
60. Wei, T., Gong, J., Jamitzky, F., Heckl, W., Stark, R., and Rossle, S. (2009) Homology modeling of human Toll-like receptors TLR7, 8, and 9 ligand-binding domains Protein Sci. 18, 1684-1691
61. Tanji, H., Ohto, U., Shibata, T., Miyake, K., and Shimizu, T. (2013) Structural reorganization of the Toll-like receptor 8 dimer induced by agonistic ligands Science 339, 1426-1429
62. Gibbard, R. J., Morley, P. J., and Gay, N. J. (2006) Conserved features in the extracellular domain of human toll-like receptor 8 are essential for pH-dependent signaling J. Biol. Chem. 281, 27503-27511
63. Chan, M., Hayashi, T., Mathewson, R. D., Yao, S., Gray, C., Tawatao, R. I., Kalenian, K., Zhang, Y., Hayashi, Y., Lao, F. S., Cottam, H. B., and Carson, D. A. (2011) Synthesis and characterization of PEGylated Toll like receptor 7 ligands Bioconjugate Chem. 22, 445-454
64. Chan, M., Hayashi, T., Kuy, C. S., Gray, C. S., Wu, C. C. N., Corr, M., Wrasidlo, W., Cottam, H. B., and Carson, D. A. (2009) Synthesis and immunological characterization of Toll-like receptor 7 agonistic conjugates Bioconjugate Chem. 20, 1194-1200
65. Kokatla, H. P., Yoo, E., Salunke, D. B., Sil, D., Ng, C. F., Balakrishna, R., Malladi, S. S., Fox, L. M., and David, S. A. (2013) Toll-like receptor-8 agonistic activities in C2, C4, and C8 modified thiazolo[4, 5-c ]quinolones Org. Biomol. Chem. 11, 1179-1198
66. Shukla, N. M., Salunke, D. B., Balakrishna, R., Mutz, C. A., Malladi, S. S., and David, S. A. (2012) Potent adjuvanticity of a pure TLR7-agonistic imidazoquinoline dendrimer PLoS One 7, e43612
67. Cusson-Hermance, N., Khurana, S., Lee, T. H., Fitzgerald, K. A., and Kelliher, M. A. (2005) Rip1 mediates the Trif-dependent Toll-like receptor 3-and 4-induced NF-kappa B activation but does not contribute to interferon regulatory factor 3 activation J. Biol. Chem. 280, 36560-36566
68. Leonard, J. N., Ghirlando, R., Askins, J., Bell, J. K., Margulies, D. H., Davies, D. R., and Segal, D. M. (2008) The TLR3 signaling complex forms by cooperative receptor dimerization Proc. Natl. Acad. Sci. U.S.A. 105, 258-263
69. Choe, J., Kelker, M. S., and Wilson, I. A. (2005) Crystal structure of human Toll-like receptor 3 (TLR3) ectodomain Science 309, 581-585
70. Toscano, F., Estornes, Y., Virard, F., Garcia-Cattaneo, A., Pierrot, A., Vanbervliet, B., Bonnin, M., Ciancanelli, M. J., Zhang, S.-Y., Funami, K., Seya, T., Matsumoto, M., Pin, J.-J., Casanova, J.-L., Renno, T., and Lebecque, S. (2013) Cleaved/associated TLR3 represents the primary form of the signaling receptor J. Immunol. 190, 764-773
71. Zhou, Y., Guo, M., Wang, X., Li, J., Wang, Y., Ye, L., Dai, M., Zhou, L., Persidsky, Y., and Ho, W. (2013) TLR3 activation efficiency by high or low molecular mass poly I:C Innate Immun. 19, 184-192
72. Barbuto, S., Idoyaga, J., Vila-Perello, M., Longhi, M. P., Breton, G., Steinman, R. M., and Muir, T. W. (2013) Induction of innate and adaptive immunity by delivery of poly dA:dT to dendritic cells Nat. Chem. Biol. 9, 250-256
73. Ivicak-Kocjan, K., Panter, G., Bencina, M., and Jerala, R. (2013) Determination of the physiological 2:2 TLR5:flagellin activation stoichiometry revealed by the activity of a fusion receptor Biochem. Biophys. Res. Commun. 435, 40-45
74. Mizel, S. B., West, A. P., and Hantgan, R. R. (2003) Identification of a sequence in human Toll-like receptor 5 required for the binding of Gram-negative Flagellin J. Biol. Chem. 278, 23624-23629
75. Yoon, S., Kurnasov, O., Natarajan, V., Hong, M., Gudkov, A. V., Osterman, A. L., and Wilson, I. A. (2012) Structural basis of TLR5-flagellin recognition and signaling Science 335, 859-864
76. Smith, K. D., Andersen-Nissen, E., Hayashi, F., Strobe, K., Bergman, M. A., Barrett, S. L. R., Cookson, B. T., and Aderem, A. (2003) Toll-like receptor 5 recognizes a conserved site on flagellin required for protofilament formation and bacterial motility Nat. Immunol. 4, 1247-1253
77. Andersen-Nissen, E., Smith, K. D., Bonneau, R., Strong, R. K., and Aderem, A. (2007) A conserved surface on Toll-like receptor 5 recognizes bacterial flagellin J. Exp. Med. 204, 393-403
78. Barton, G. M., Kagan, J. C., and Medzhitov, R. (2006) Intracellular localization of Toll-like receptor 9 prevents recognition of self DNA but facilitates access to viral DNA Nat. Immunol. 7, 49-56
79. Rutz, M., Metzger, J., Gellert, T., Luppa, P., Lipford, G. B., Wagner, H., and Bauer, S. (2004) Toll-like receptor 9 binds single-stranded CpG-DNA in a sequence-and pH-dependent manner Eur. J. Immunol. 34, 2541-2550
80. Vollmer, J., Weeratna, R., Payette, P., Jurk, M., Schetter, C., Laucht, M., Wader, T., Tluk, S., Liu, M., Davis, H. L., and Krieg, A. M. (2004) Characterization of three CpG oligodeoxynucleotide classes with distinct immunostimulatory activities Eur. J. Immunol. 34, 251-262
81. Krug, A., Rothenfusser, S., Hornung, V., Jahrsdorfer, B., Blackwell, S., Ballas, Z. K., Endres, S., Krieg, A. M., and Hartmann, G. (2001) Identification of CpG oligonucleotide sequences with high induction of IFN-/ in plasmacytoid dendritic cells Eur. J. Immunol. 31, 2154-2163
82. Krieg, A. M. and Wagner, H. (2000) Causing a commotion in the blood: immunotherapy progresses from bacteria to bacterial DNA Immunol. Today 21, 521-526
83. Krieg, A. M., Yi, A.-K., Matson, S., Waldschmidt, T. J., Bishop, G. A., Teasdale, R., Koretzky, G. A., and Klinman, D. M. (1995) CpG motifs in bacterial DNA trigger direct B-cell activation Nature 374, 546-549
84. Krieg, A. M. (2000) The role of CpG motifs in innate immunity Curr. Opin. Immunol. 12, 35-43
85. Krieg, A. M. (2002) CpG motifs in bacterial DNA and their immune effects Annu. Rev. Immunol. 20, 709-760
86. Haas, T., Metzger, J., Schmitz, F., Heit, A., Muller, T., Latz, E., and Wagner, H. (2008) The DNA sugar backbone 2 deoxyribose determines Toll-like receptor 9 activation Immunity 28, 315-323
87. Li, Y., Berke, I. C., and Modis, Y. (2012) DNA binding to proteolytically activated TLR9 is sequence-independent and enhanced by DNA curvature EMBO J. 31, 919-931
88. Ewald, S. E., Engel, A., Lee, J., Wang, M., Bogyo, M., and Barton, G. M. (2011) Nucleic acid recognition by Toll-like receptors is coupled to stepwise processing by cathepsins and asparagine endopeptidase J. Exp. Med. 208, 643-651
89. Park, B., Brinkmann, M. M., Spooner, E., Lee, C. C., Kim, Y.-M., and Ploegh, H. L. (2008) Proteolytic cleavage in an endolysosomal compartment is required for Toll-like receptor 9 activation Nat. Immunol 9, 1407-1414
90. Li, Y., Berke, I. C., and Modis, Y. (2012) DNA binding to proteolytically activated TLR9 is sequence-independent and enhanced by DNA curvature EMBO J. 31, 919-931
91. Krummen, M., Balkow, S., Shen, L., Heinz, S., Loquai, C., Probst, H.-C., and Grabbe, S. (2010) Release of IL-12 by dendritic cells activated by TLR ligation is dependent on MyD88 signaling, whereas TRIF signaling is indispensable for TLR synergy J. Leukocyte Biol. 88, 189-199
92. Makela, S. M., Strengell, M., Pietila, T. E., Osterlund, P., and Julkunen, I. (2009) Multiple signaling pathways contribute to synergistic TLR ligand-dependent cytokine gene expression in human monocyte-derived macrophages and dendritic cells J. Leukocyte Biol. 85, 664-672
93. Wu, H. (2013) Higher-order assemblies in a new paradigm of signal transduction Cell 153, 287-292
94. Trinchieri, G. and Sher, A. (2007) Cooperation of Toll-like receptor signals in innate immune defence Nat. Rev. Immunol. 7, 179-190
95. Garcia-Cordero, J. L., Nembrini, C., Stano, A., Hubbell, J. A., and Maerkl, S. J. (2013) A high-throughput nanoimmunoassay chip applied to large-scale vaccine adjuvant screening Integr. Biol. 5, 650-658
96. Timmermans, K., Plantinga, T. S., Kox, M., Vaneker, M., Scheffer, G. J., Adema, G. J., Joosten, L. A. B., and Netea, M. G. (2013) Blueprints of signaling interactions between pattern recognition receptors: Implications for the design of vaccine adjuvants Clin. Vaccine Immunol. 20, 427-432
97. Napetschnig, J. and Wu, H. (2013) Molecular Basis of NF-B Signaling Annu. Rev. Biophys. 42, 443-468
98. Lin, S.-C., Lo, Y.-C., and Wu, H. (2010) Helical assembly in the MyD88-IRAK4-IRAK2 complex in TLR/IL-1R signalling Nature 465, 885-890
99. Barton, G. M. and Kagan, J. C. (2009) A cell biological view of Toll-like receptor function: regulation through compartmentalization Nat. Rev. Immunol. 9, 535-542
100. Medzhitov, R. and Janeway, C. A., Jr (1997) Innate immunity: impact on the adaptive immune response Curr. Opin. Immunol. 9, 4-9